SEC Form 4 · accession 0001534424-17-000413
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimble L. Jenkins
Director
Period of report
Oct 4, 2017
Accepted (ET)
Oct 5, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 4, 2017 | A | 1,280 | $2.47 | A | 35,918 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $2.60 | Oct 4, 2017 | A | 300,000 | A | — | Oct 4, 2027 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017.
- F2The shares subject to this option will vest in full on the first anniversary of the grant date, October 4, 2018.